Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | inositol allo- | 61 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 64 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 66 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 68 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 71 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 72 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 75 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 78 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 78 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 78 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 79 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 81 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 81 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 85 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 86 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 87 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 88 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 89 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 91 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 91 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 92 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 92 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 93 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 93 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 94 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 95 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 96 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 98 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 98 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 99 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 100 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 100 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 100 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 101 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 102 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 103 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 104 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 105 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 105 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 105 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 106 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 106 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 107 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 107 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 109 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 109 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 109 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 109 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 109 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 110 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 110 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 111 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 111 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 112 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 112 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 112 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 113 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 113 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 114 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 115 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 115 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 115 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 115 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 115 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 116 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 116 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 117 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 117 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 118 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 118 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 118 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 119 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 119 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 120 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 120 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 120 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 120 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 121 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 121 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 122 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 122 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 123 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 124 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 124 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 125 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 127 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 128 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 128 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 129 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 129 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 129 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 130 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 131 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 132 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 132 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 132 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 133 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 133 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 134 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 135 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 136 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 139 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 139 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 140 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 141 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 141 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 142 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 142 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 142 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 143 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 143 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 144 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 145 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 150 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 151 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 151 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 151 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 152 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 152 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 153 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 153 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 154 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 154 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 156 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 156 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 157 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 157 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 158 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 159 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 161 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 162 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 163 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 164 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 168 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 168 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 169 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 170 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 171 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 172 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 172 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 172 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 172 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 174 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 174 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 175 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 175 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 178 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 178 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 180 | Counts | 50-54 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 180 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 181 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 181 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 186 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 187 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 188 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 188 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 191 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 191 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 192 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 192 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 193 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 194 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 197 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 198 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 198 | Counts | 60-64 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 199 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 201 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 201 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 207 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 210 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 211 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 212 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 213 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 215 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 216 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 217 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 218 | Counts | 55-59 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 218 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 221 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 223 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 224 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 225 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 232 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 234 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 235 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 236 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 237 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 243 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 243 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | inositol allo- | 245 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | inositol allo- | 248 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | inositol allo- | 248 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 249 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 257 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 264 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | inositol allo- | 266 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | inositol allo- | 270 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | inositol allo- | 284 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 284 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | inositol allo- | 294 | Counts | 60-64 | Male | Current | - |
Return to search page